Opens in a new tab

Scalp Cooling: Implementation of a Program at a Multisite Organization

Clin J Oncol Nurs. 2018 Oct 1;22(5):534-541.
Type:
Multicenter Study
Link:
https://pubmed.ncbi.nlm.nih.gov/3023951…
PMID:
30239512
DOI:
10.1188/18.CJON.534-541
Authors:

Erica Fischer-Cartlidge1, Mikel Ross1, Karen Hernández1, Ashley Featherstone1, Curt Haase1

Access Paper

1Memorial Sloan Kettering Cancer Center

Related papers:

Abstract P5-08-10: Safety and Tolerability of Paxman Scalp Cooling at Lower Temperatures to Improve Efficacy with Anthracycline Chemotherapy

View

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer

View

Scalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial

View

Abstract

Purpose

This article describes the experience of a large multisite organization that implemented a machine-based scalp cooling program.

Methods

Nursing staff led an interprofessional team that addressed components of the program. As a result, eight sites within the authors’ organization simultaneously began offering scalp cooling via machine using a single unified process. This approach was then successfully replicated one year later to prepare six additional sites to launch scalp cooling for other solid tumor types beyond breast cancer.

Results

Using a structured, collaborative, and interprofessional approach to the implementation of a scalp cooling program at the authors’ institution allowed for standardization of care across sites. This approach can be replicated at other healthcare institutions.

Keywords

  • Alopecia prevention
  • program implementation
  • scalp cooling
  • staff training

Related papers

“Dear hair loss” – illness perceptions of female patients with chemotherapy-induced alopecia

Chemotherapy-induced alopecia (CIA) is one of the most common and distressing side effects of chemotherapy treatment. This study aims to assess the illness perceptions of…

View

(pre-)Clinical research to understand alopecia and improve cooling results

• Authors: international multi-disciplinary special interest group (SIG) on chemotherapy-induced alopecia (CIA) & scalp cooling • Pathobiology of CIA is still not fully understood1 •…

View

A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention

Chemotherapy-induced alopecia (CIA) is the most visibly distressing side effect of commonly administered chemotherapeutic agents. Because psychological health has huge relevance to lifestyle, diet, and…

View
Get the Paxman System

Wherever you are in the world, it’s easy to give patients access to our chemotherapy side effect management solutions and a degree of control. Fill out the form to get started.

Get Paxman in your country with our global locator